Concepedia

Author

Klaus G. Parhofer

Ludwig-Maximilians-Universität MünchenORCID

Also Known As

Christoph B Olivier, Elena Osto, H.-J Mller, J. R. G. Juanatey, K G Parhofer, K Parhofer, K. G. Parhofer, K. Parhofer, K.G Parhofer, K.G. Parhofer

497

Publications

20.3K

Citations

62

H-Index

121

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenLMU KlinikumHelmholtz Zentrum MünchenHeidelberg UniversityCharité - Universitätsmedizin Berlin
KG

About

Klaus G. Parhofer is an author at Ludwig-Maximilians-Universität München specializing in medicine, cardiovascular disease, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

49

3.6K

2

Health Sciences

17

20

818

3

Public Health

16

16

2.2K

4

Biochemistry

9

9

380

5

Engineering

1

1

11

Klaus G. Parhofer

×

125

Publications

9.7K

Citations

48

H-Index

YearCitations

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes,

European Heart Journal

2022

1.1K

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Marina Cuchel, Éric Bruckert, Henry N. Ginsberg,

European Heart Journal

2014

1K

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types

Roland Buettner, Klaus G. Parhofer, Matthias Woenckhaus,

Journal of Molecular Endocrinology

2006

691

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

Michael Lehrke, Alexander Becker, Martin Greif,

European Journal of Endocrinology

2009

294

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons,

The Lancet

2021

285

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Marina Cuchel, Frederick J. Raal, Robert A. Hegele,

European Heart Journal

2023

280

Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis

Martin Greif, Alexander Becker, Franz von Ziegler,

Arteriosclerosis Thrombosis and Vascular Biology

2009

269

Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study

Pedro de Pablos‐Velasco, Klaus G. Parhofer, Clare Bradley,

Clinical Endocrinology

2012

209

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo,

Current Vascular Pharmacology

2011

197

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak,

European Heart Journal

2016

194

Page 1